Patent ID: 11897897
Assignee: VIIV HEALTHCARE UK (NO.4) LIMITED
Field: nan (nan)
Classification: CPC nan | IPC C

Claim 12:
13. A pharmaceutical composition comprising a crystalline form (Form B) of cabotegravir sodium characterized by having a powder X-ray diffractogram substantially in accordance with FIG. 1, when measured at a temperature in the range of from 20 to 30° C. with Cu-Kalpha1,2 radiation having a wavelength of 0.15419 nm,
wherein cabotegravir sodium is present in an amount selected from the group consisting of 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 55 mg, 60 mg, 65 mg, 70 mg, 75 mg, 80 mg, 85 mg, and 90 mg, calculated as cabotegravir.